Advertisement
Advertisement
NBTX
Nanobiotix S.A. - ADR
31.13
USDSponsored
+0.50
+1.62%
Mar 26, 15:02 UTC -4
Open
NBTX Earnings Reports
Positive Surprise Ratio
NBTX beat 4 of 15 last estimates.
27%
Next Report
Next Week
Date of Next Report
Mar 31, 2026
Estimate for Q4 25 (Revenue/ EPS)
$59.82M
/$0.55
Implied change from Q-- -- (Revenue/ EPS)
--
/--
Implied change from Q4 24 (Revenue/ EPS)
-462.99%
/-156.12%
Nanobiotix S.A. - ADR earnings per share and revenue
On --, NBTX reported earnings of -- USD per share (EPS) for -- --, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.
Looking ahead to Q4 25, 4 analysts forecast an EPS of 0.55 USD, with revenue projected to reach 59.82 million USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Precigen, Inc. Common Stock
Report Date
Mar 25, 2026 For Q4 25
Estimate
-$0.08
Actual
-$0.01
Surprise
+88.24%
Absci Corporation Common Stock
Report Date
Mar 24, 2026 For Q4 25
Estimate
-$0.19
Actual
-$0.23
Surprise
-16.04%
Candel Therapeutics, Inc. Common Stock
Report Date
Mar 26, 2026 For Q4 25
Estimate
-$0.25
Actual
-$0.54
Surprise
-115.31%
LENZ Therapeutics, Inc. Common Stock
Report Date
Mar 24, 2026 For Q4 25
Estimate
-$0.99
Actual
-$1.15
Surprise
-17.10%
Fennec Pharmaceuticals Inc. Common Stock
Report Date
Mar 24, 2026 For Q4 25
Estimate
$0.03
Actual
-$0.11
Surprise
-408.12%
Equillium, Inc. Common Stock
Report Date
Mar 25, 2026 For Q4 25
Estimate
-$0.06
Actual
-$0.04
Surprise
+35.28%
MaxCyte, Inc. Common Stock
Report Date
Mar 24, 2026 For Q4 25
Estimate
-$0.08
Actual
-$0.06
Surprise
+26.47%
Celcuity Inc. Common Stock
Report Date
Mar 25, 2026 For Q4 25
Estimate
-$1.06
Actual
-$0.97
Surprise
+8.72%
TELA Bio, Inc. Common Stock
Report Date
Mar 24, 2026 For Q4 25
Estimate
-$0.18
Actual
-$0.16
Surprise
+14.12%
Dyadic International, Inc.
Report Date
Mar 25, 2026 For Q4 25
Estimate
-$0.04
Actual
-$0.06
Surprise
-30.72%
FAQ
What were Nanobiotix S.A. - ADR's earnings and revenue for the latest quarter Q-- --?
For Q-- --, Nanobiotix S.A. - ADR reported EPS of --, Inline estimates by --, and revenue of --, -- -- expectations.
How did the market react to Nanobiotix S.A. - ADR's Q-- -- earnings?
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
When is Nanobiotix S.A. - ADR expected to report next?
The next earning report is scheduled for Mar 31, 2026.
What are the forecasts for Nanobiotix S.A. - ADR's next earnings report?
Based on 4
analysts, Nanobiotix S.A. - ADR is expected to report EPS of $0.55 and revenue of $59.82M for Q4 2025.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement